<!DOCTYPE html>
<html lang="en-US">

<head>
<!-- https://www.ncbi.nlm.nih.gov/projects/msaviewer/ -->
<!-- This viewer will expire in 1-2 months. Update or embed our own -->


<!-- <script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/projects/msaviewer/js/multialign.js"></script></head> -->


  <script async src="https://www.googletagmanager.com/gtag/js?id=UA-199638391-1"></script>
  <script>
    window.dataLayer = window.dataLayer || [];
    function gtag(){dataLayer.push(arguments);}
    gtag('js', new Date());
    gtag('config', 'UA-199638391-1');
  </script>

<meta charset="UTF-8">

	<title>
        SARS-CoV-2 variants
    </title>


<!-- Begin Jekyll SEO tag v2.7.1 -->
<title>SARS-CoV-2 variants | Open-source tracking for emerging SARS-CoV-2 variants that pose a risk based on COVID-19 vaccine genetics.</title>
<meta name="generator" content="Jekyll v3.9.0" />
<meta property="og:title" content="SARS-CoV-2 variants" />
<meta property="og:locale" content="en_US" />
<meta name="description" content="Open-source tracking for emerging SARS-CoV-2 variants that pose a risk based on COVID-19 vaccine genetics." />
<meta property="og:description" content="Open-source tracking for emerging SARS-CoV-2 variants that pose a risk based on COVID-19 vaccine genetics." />
<link rel="canonical" href="http://localhost:4000/pages/Vaccine_details.html" />
<meta property="og:url" content="http://localhost:4000/pages/Vaccine_details.html" />
<meta property="og:site_name" content="SARS-CoV-2 variants" />
<meta name="twitter:card" content="summary" />
<meta property="twitter:title" content="SARS-CoV-2 variants" />
<script type="application/ld+json">
{"description":"Open-source tracking for emerging SARS-CoV-2 variants that pose a risk based on COVID-19 vaccine genetics.","url":"http://localhost:4000/pages/Vaccine_details.html","headline":"SARS-CoV-2 variants","@type":"WebPage","@context":"https://schema.org"}</script>
<!-- End Jekyll SEO tag -->

<link rel="preconnect" href="https://fonts.gstatic.com">
<link rel="preload" href="https://fonts.googleapis.com/css?family=Open+Sans:400,700&display=swap" as="style" type="text/css" crossorigin>
<meta name="viewport" content="width=device-width, initial-scale=1">
<meta name="theme-color" content="#157878">
<meta name="apple-mobile-web-app-status-bar-style" content="black-translucent">
<link rel="stylesheet" href="/assets/css/style.css?v=7b98ae6e65e93d276f50cdef728aea4e0e1320e7">
</head>

<body>
<!-- <a id="skip-to-content" href="#content">Skip to the content.</a> -->
<header class="page-header" role="banner">

<div class="container particle particle-1"></div>
<div class="container particle particle-2"></div>
<div class="container particle particle-3"></div>
<div class="container particle particle-4"></div>

<div class="project-name" >
	<h1> SARS-CoV-2 variants </h1>
  <h2 class="project-tagline">Open-source tracking for emerging SARS-CoV-2 variants that pose a risk based on COVID-19 vaccine genetics.</h2>
  


</div>  
</header>

<!-- MSA viewer -->
<div id="msaviewer_x6f6y" class="MultiAlignViewerApp" data-autoload>
<a href="?embedded=true&anchor=-1&coloring=fbd&key=qhkwwLYbacLFNSfF5iQRO0GVWVAGIQgkBCIsNDgwKh67Eg5CyHhYWzczAoYJoxPeQsYf0gH2WvMd6QnkD-ID-THQDN4g4go,jT4X55E8TuXiEgDiwQM2HGayfnYhBy8CIwQLEh8WDTicNClk714CS8TL8QFrLrlT6Eu1X6t78H63ZKNppW-pdJtdplOKb6A&track_config=protein_default&from=207&to=278&columns=d:120,b:55,x:17,aln,e:55,o:150&appname=ncbi_msav_demo"></a>
</div>

	<!-- <div id="7db9ZE" class="SeqViewerApp" data-autoload> -->
<!-- <a href="?embedded=true&url=https://raw.githubusercontent.com/DylanLawless/SARS-CoV-2-VOC.github.io/main/UCSCGenes_exon20.bed&appname=MyCompany_MyApp"></a> -->
<!-- </div> -->

    <main id="content" class="main-content" role="main">
      
<ul>
  <li>BioNTech/Pfizer: BNT162b2
    <ul>
      <li>Modified mRNA-in-lipid-nanoparticle vaccine</li>
      <li>Expressing a modified S protein.</li>
      <li>Stabiliazation by proline substitutions p.K986P, p.V987P.</li>
    </ul>
  </li>
  <li>Moderna: mRNA-1273
    <ul>
      <li>Modified mRNA-in-lipid-nanoparticle vaccine</li>
      <li>Expressing a modified S protein.</li>
      <li>Stabiliazation by proline substitutions p.K986P, p.V987P.</li>
    </ul>
  </li>
  <li>Janssen/Johnson &amp; Johnson: Ad26.COV2-S aka JNJ-78436735
    <ul>
      <li><a href="https://www.biorxiv.org/content/10.1101/2020.07.30.227470v1">Pre-prindt</a>, <a href="https://www.nature.com/articles/s41541-020-00243-x">Published</a>.</li>
      <li>Adenovirus serotype 26 (Ad26) viral vector vaccine</li>
      <li>Expressing a modified S protein.</li>
      <li>S protein of SARS-CoV-2 corresponding to positions 21,536–25,384 in SARS-CoV-2 isolate Wuhan-Hu-1 (genome MN908947 (18-MAR-2020))<a href="https://www.nature.com/articles/s41541-020-00243-x">Published</a>.</li>
      <li>For Ad26.S.PP, the two stabilising variants p.(Lys986_Val987delinsProPro) are included as well as two mutations in the furin cleavage site that preserve the prefusion conformation and blocks shedding of S1.</li>
      <li>The furin cleavage site was abolished by amino acid changes p.R682S and p.R685G.</li>
      <li>Stabiliazation by proline substitutions p.K986P, p.V987P.</li>
      <li><a href="https://varnomen.hgvs.org/recommendations/protein/variant/delins/">HGVS notation</a> would be: p.[Arg682Ser;p.Arg685Gln] and p.(Lys986_Val987delinsProPro).</li>
    </ul>
  </li>
  <li>Novavax: NVX-CoV2373
    <ul>
      <li>A protein subunit vaccine containing a doubly modified S protein, with adjuvant.</li>
      <li>Part of a 27.2nm nanoparticle.</li>
      <li>S protein of SARS-CoV-2 corresponding to GenBank MN908947 nucleotides 21563-25384 <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584426/">as published</a>.</li>
      <li>Contains the modified S protein with the two Proline substitutions, K986P and V987P. Additionally, three amino acids are changed (682-RRAR-685 to 682-QQAQ-685) to protect the protein against proteases.</li>
      <li><a href="https://varnomen.hgvs.org/recommendations/protein/variant/delins/">HGVS notation</a> would be: p.[Arg682_Arg683delinsGlnGln;Arg685Gln] and p.(Lys986_Val987delinsProPro),
a simple list would even be better: p.R682Q, p.R683Q, p.R685Q, p.K986P, and p.V987P.</li>
      <li>Saponin-based Matrix-M adjuvent.</li>
      <li>Protein expression by a baculovirus in an Sf9 insect infection culture.</li>
      <li><a href="https://www.biorxiv.org/content/10.1101/2020.06.29.178509v1.full.pdf">Pre-print</a></li>
      <li>Delivery in lipid nanoparticle</li>
    </ul>
  </li>
  <li>Gamaleya Research Institute of Epidemiology and Microbiology: Sputnik V
    <ul>
      <li>aka Гам-КОВИД-Вак (Gam-COVID-Vac).</li>
      <li>Two differnt adenovirus viral vectors.</li>
      <li>Uses two different adenovirus serotypes; <a href="https://sputnikvaccine.com/about-vaccine/">recombinant Ad26 (dose 1) and recombinant Ad5 (dose 2)</a>.</li>
      <li>Both carrying the gene for Spike glycoprotein (rAd26-S and rAd5-S).</li>
      <li>Antigen insert is an “unmodified” full-length S-protein (no reference sequence).</li>
      <li>Produced in HEK293 cell line.</li>
      <li>No reference sequence found</li>
      <li>The first major paper [Logunov et al Lancet. 2020] is this clinical trial of frozen and lyophilised vaccine. It mentions previous unpublished pre-clinical trials. <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471804/">Published</a>.</li>
    </ul>
  </li>
  <li>Curevac: CVnCoV
    <ul>
      <li>Unmodified mRNA-in-lipid-nanoparticle vaccine</li>
      <li>Expressing a modified S protein.</li>
      <li>Based on genome from first isolate <a href="https://www.ncbi.nlm.nih.gov/nuccore/NC_045512.2">NC_045512.2</a>, Spike glycoprotein <a href="https://www.ncbi.nlm.nih.gov/protein/YP_009724390.1">YP_009724390.1</a>.</li>
      <li>full-length S featuring K986P and V987P mutations.</li>
      <li><a href="https://pubmed.ncbi.nlm.nih.gov/33863911/">https://pubmed.ncbi.nlm.nih.gov/33863911/</a></li>
    </ul>
  </li>
  <li>Oxford/AstraZeneca: AZD1222 (formerly ChAdOx1 nCoV-19)
    <ul>
      <li>A viral vector vaccine</li>
      <li>Viral vector (ChAdOx1 - chimpanzee adenovirus Oxford 1, <a href="https://pubmed.ncbi.nlm.nih.gov/22808149/">as published</a>)</li>
      <li>Expressing the unmodified S protein.</li>
      <li>Unmodified MN908947 from reference sequence</li>
      <li><a href="http://www.thelancet.com/retrieve/pii/S0140673620316044">Folegatti et al, Lancet July 2020</a></li>
    </ul>
  </li>
</ul>



	<footer class="site-footer">
		
		<span class="site-footer-owner">
		<a href="https://lawlessgenomics.com"><img src="/images/logos/logo4.2_150ppi.png" 
		alt="Logo image" width="17.85" height="27.25" /></a>
		<a href="https://github.com/DylanLawless/SARS-CoV-2-VOC.github.io">SARS-CoV-2-VOC.github.io</a> is maintained by <a href="https://github.com/DylanLawless">DylanLawless</a>
		</span>
		
	<!-- <span class="site-footer-credits">This page was generated by <a href="https://pages.github.com">GitHub Pages</a>.</span> -->
	<form action="https://www.paypal.com/donate" method="post" target="_top">
<input type="hidden" name="hosted_button_id" value="UU3F4ND2JAP2W" />
<input type="image" src="https://www.paypalobjects.com/en_US/i/btn/btn_donate_SM.gif" border="0" name="submit" title="PayPal - The safer, easier way to pay online!" alt="Donate with PayPal button" />
<img alt="" border="0" src="https://www.paypal.com/en_IE/i/scr/pixel.gif" width="1" height="1" />
</form>
	<!--- https://www.paypal.com/donate?hosted_button_id=UU3F4ND2JAP2W --->
	</footer>
    </main>
  </body>
</html>
